Association of the endothelial nitric oxide synthase (ecNOS) gene polymorphism with carotid atherosclerosis in type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 72, Issue 3, 2006, Pages 322-327

  Park, Ji Hyun ^a   Kim, Ji Hye ^a   Kim, Won Ho ^b   Kim, Dal Sik ^c   Park, Tae Sun ^a   Baek, Hong Sun ^a  

^a Chonbuk National University   (South Korea)

^b Research Institute of Clinical Medicine   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

Author keywords

Carotid atherosclerosis; Diabetes mellitus; Nitric oxide synthase; Polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DEMOGRAPHY; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; UNIVARIATE ANALYSIS; WAIST HIP RATIO;

ADULT; AGED; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 33646723860     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.11.002     Document Type: Article

References (28)

1. Beckman J.A., Creager M.A., and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287 (2002) 2570-2581
2. Gibbons G.W. Management of the diabetic foot complication. In: Degroot L.J., and Jameson J.L. (Eds). Endocrinology. fourth ed. vol. 1 (2001), W.B. Saunders Company, Philadelphia 903-907
3. Gross S.S., and Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57 (1995) 737-769
4. Albrecht E.W., Stegeman C.A., Heeringa P., Henning R.H., and van Goor H. Protective role of endothelial nitric oxide synthase. J. Pathol. 199 (2003) 8-17
5. Marsden P.A., Heng H.H., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268 (1993) 17478-17488
6. Wang X.L., and Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 70 (2000) 241-251
7. Hou L., Osei-Hyiaman D., Yu H., Ren Z., Zhang Z., Wang B., et al. Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients. Neurology 56 (2001) 490-496
8. Bonnardeaux A., Nadaaud S., Charru A., Jeunemaitre X., Corvol P., and Soubrier F. Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 91 (1995) 96-102
9. Miyamoto Y., Saito Y., Kajiyama N., Yoshimura M., Shimasaki Y., Nakayama M., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32 (1998) 3-8
10. Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245 (1998) 190-193
11. Wang X.L., Mahaney M.C., Sim A.S., Wang J., Wang J., Blangero J., et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3147-3153
12. Pieper G.M. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 42 (1999) 204-213
13. Bucala R., Tracey K.J., and Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87 (1991) 432-438
14. Cardiovascular Health Study Collaborative Research Group, O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson S.K. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N. Engl. J. Med. 340 (1999) 14-22
15. Hodis H.N., Mack W.J., LaBree L., Selzer R.H., Liu C.R., Liu C.H., et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann. Intern. Med. 128 (1998) 262-269
16. Chambless L.E., Heiss G., Folsom A.R., Rosamond W., Szklo M., Sharrett A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am. J. Epidemiol. 146 (1997) 483-494
17. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab. Med. 15 (1998) 539-553
18. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
19. Bierman E.L. George Lyman Duff Memorial Lecture: atherogenesis in diabetes. Arterioscler. Thromb. 12 (1992) 647-656
20. Simon D.I., Stamler J.S., Jaraki O., Keaney J.F., Osborne J.A., Francis S.A., et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler. Thromb. 13 (1993) 791-799
21. Caterina R.De., Libby P., Peng H.-B., Thanniekal V.J., Rajavashisth T.B., Gimbrone Jr. M.A., et al. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96 (1995) 60-68
22. Zeiher A.M., Fisslthaler B., Schray-Utz B., and Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein I in cultured human endothelial cells. Circ. Res. 76 (1995) 980-986
23. Wang B.Y., Candipan R.C., Arjomandi M., Hsiun P.T., Tsao P.S., and Cooke J.P. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J. Am. Coll. Cardiol. 28 (1996) 1573-1579
24. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83 (1989) 1774-1777
25. Sarkar R., Meinberg E.G., Stanley J.C., Gordon D., and Webb R.C. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78 (1996) 225-230
26. Wang J., Dudley D., and Wang X.L. Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler. Thromb. Vasc. Biol. 22 (2002) e1-e4
27. Fatini C., Sofi F., Sticchi E., Gensini F., Gori A.M., Fedi S., et al. Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am. Heart J. 147 (2004) 516-521
28. Li R., Lyn D., Lapu-Bula R., Oduwole A., Igho-Pemu P., Lankford B., et al. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am. J. Hypertens. 17 (2004) 560-567